Thermo Fisher's Q1 Revenues Climb 3 Percent

The firm's clinical diagnostics business saw double-digit growth, fueled by sales of its biomarker test kits and a strong flu season.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.